Hostname: page-component-7479d7b7d-k7p5g Total loading time: 0 Render date: 2024-07-11T13:58:13.487Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost Management: The Economist's Viewpoint

Published online by Cambridge University Press:  06 August 2018

Alan Maynard
Alan Maynard*
Affiliation:
Economics and Director of the Centre for Health Economics, University of York, York YO1 5DD
Get access Rights & Permissions [Opens in a new window]

Extract

The role of the economist is to evaluate therapeutic options so as to identify both the value of what is given up to provide care (the cost) and the value of what is gained, in terms of improved health status (the benefit). The function of the economic evaluation is to inform choices: these will be determined by clinicians and managers. By informing the choice process, the economic calculus makes decisionmaking more ‘transparent’ and makes those who allocate resources more accountable to their peers, purchasers, and patients.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 163 , Issue S20: The Economic Evaluation of Antidepressant Drug Therapy , July 1993 , pp. 7 - 13
Copyright
Copyright © 1993 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beresford, S. A. A., Chant, A. D. B., Jones, H. O., et al (1978) Varicose veins: a comparison of surgery and injection/compression sclerotherapy. Lancet, i, 921–924.CrossRefGoogle Scholar
Cairns, J. (1992) Discounting and health benefits: another perspective. Health Economics, 1, 76–79.Google Scholar
Donaldson, C. (1990) Willingness to pay for publicly provided goods: a possible measure of benefit. Journal of Health Economics, 9, 103–118.CrossRefGoogle ScholarPubMed
Drummond, M. F., Stoddan, G. L. & Torrence, G. (1987) Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford Medical.Google Scholar
Eisenberg, L. (1992) Treating depression and anxiety in primary care: closing the gap between knowledge and practice. New England Journal of Medicine, 326, 1080–1084.CrossRefGoogle ScholarPubMed
Euroqol Group (1990) Euroqol - a new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.CrossRefGoogle Scholar
Gerard, K., Donaldson, C. & Maynard, A. (1989) The cost of diabetes. Diabetic Medicine, 6, 164–170.Google Scholar
Henry, J. A. & Martin, A. J. (1987) The risk-benefit assessment of anti-depressant drugs. Medical Toxicology, 2, 445–462.CrossRefGoogle Scholar
Johnson, J., Weissman, M. M. & Klerman, G. L. (1992) Service utilisation and social morbidity associated with depressive symptoms in the community. Journal of the American Medical Association, 267, 1478–1483.CrossRefGoogle ScholarPubMed
Jones-Lee, M. W. (1976) Value of Life: an Economic Analysis. London: Martin Robertson.Google Scholar
Kind, P. (1992) Unpublished mimeograph. Centre for Health Economics, University of York.Google Scholar
Lowson, K. V., Drummond, M. F. & Bishop, J. M. (1981) Costing new services: long term domiciliary oxygen therapy. Lancet, i, 1146–1149.CrossRefGoogle Scholar
Ludbrook, A. (1981) A cost-effectiveness analysis of the treatment of chronic renal failure. Applied Economics, 13, 337–350.CrossRefGoogle Scholar
Maynard, A. (1990a) The costs of addiction. In Controlling Legal Addiction (eds Robinson, D., Maynard, A. & Chester, R.). London: Macmillan.Google Scholar
Maynard, A. (1990b) The design of future cost-benefit studies. American Health Journal, 119, 761–765.Google ScholarPubMed
Maynard, A. (1991) Developing the health care market. Economic Journal, 101, 1277–1286.CrossRefGoogle Scholar
Mooney, G. (1977) The Valuation of Human Life. London: Macmillan.CrossRefGoogle Scholar
O'Donnell, O., Maynard, A. & Wright, K. (1988a) Evaluating Mental Health Care: the Role of Economics. Discussion paper 50, Centre for Health Economics, University of York.Google Scholar
O'Donnell, O., Maynard, A. & Wright, K. (1988b) The Economic Evaluation of Mental Health Care: a Review. Discussion paper 51, Centre for Health Economics, University of York.Google Scholar
Parsonage, M. & Neuberger, H. (1992) Discounting and health benefits. Health Economics, 1, 71–76.CrossRefGoogle ScholarPubMed
Piachaud, D. & Weddell, J. M. (1972) The economics of treating varicose veins. International Journal of Epidemiology, 1, 287–294.CrossRefGoogle ScholarPubMed
Spilker, B. (1990) Quality of Life Assessments in Clinical Trials. New York: Raven Press.Google Scholar
Spilker, B., Molinek, F. R., Johnston, K. A., et al (1990) Quality of life bibliography and indexes. Medical Care (suppl.), 28 December, p. 12.Google Scholar
Stewart, A. L. & Ware, J. E. (eds) (1992) Measuring Functioning and Well Being: the Medical Outcomes Study Approach. Durham, North Carolina: Duke University Press.Google Scholar
West, R. (1992) Depression. London: Office of Health Economics. Williams, A. (1974) The cost benefit approach. British Medical Bulletin, 30, 252–256.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.